GB201814207D0 - Combination Therapy - Google Patents

Combination Therapy

Info

Publication number
GB201814207D0
GB201814207D0 GBGB1814207.5A GB201814207A GB201814207D0 GB 201814207 D0 GB201814207 D0 GB 201814207D0 GB 201814207 A GB201814207 A GB 201814207A GB 201814207 D0 GB201814207 D0 GB 201814207D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1814207.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1814207.5A priority Critical patent/GB201814207D0/en
Publication of GB201814207D0 publication Critical patent/GB201814207D0/en
Priority to MX2021001908A priority patent/MX2021001908A/en
Priority to CA3107085A priority patent/CA3107085A1/en
Priority to US17/271,108 priority patent/US20210322564A1/en
Priority to JP2021509758A priority patent/JP2021535110A/en
Priority to AU2019332979A priority patent/AU2019332979A1/en
Priority to EP19762358.0A priority patent/EP3843748A1/en
Priority to PCT/EP2019/073212 priority patent/WO2020043878A1/en
Priority to CN201980056828.XA priority patent/CN112638392B/en
Priority to KR1020217006539A priority patent/KR20210054520A/en
Priority to BR112021003675-0A priority patent/BR112021003675A2/en
Priority to SG11202101518QA priority patent/SG11202101518QA/en
Priority to IL280968A priority patent/IL280968A/en
Priority to PH12021550376A priority patent/PH12021550376A1/en
Ceased legal-status Critical Current

Links

GBGB1814207.5A 2018-08-31 2018-08-31 Combination Therapy Ceased GB201814207D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1814207.5A GB201814207D0 (en) 2018-08-31 2018-08-31 Combination Therapy
SG11202101518QA SG11202101518QA (en) 2018-08-31 2019-08-30 Combination therapy
EP19762358.0A EP3843748A1 (en) 2018-08-31 2019-08-30 Combination therapy
CN201980056828.XA CN112638392B (en) 2018-08-31 2019-08-30 Combination therapy
US17/271,108 US20210322564A1 (en) 2018-08-31 2019-08-30 Combination therapy
JP2021509758A JP2021535110A (en) 2018-08-31 2019-08-30 Combination therapy
AU2019332979A AU2019332979A1 (en) 2018-08-31 2019-08-30 Combination therapy
MX2021001908A MX2021001908A (en) 2018-08-31 2019-08-30 Combination therapy.
PCT/EP2019/073212 WO2020043878A1 (en) 2018-08-31 2019-08-30 Combination therapy
CA3107085A CA3107085A1 (en) 2018-08-31 2019-08-30 Combination of anti-cd19 antibody-pyrroloenzodiazepine conjugate and ve netoclax
KR1020217006539A KR20210054520A (en) 2018-08-31 2019-08-30 Combination therapy
BR112021003675-0A BR112021003675A2 (en) 2018-08-31 2019-08-30 combination therapy
IL280968A IL280968A (en) 2018-08-31 2021-02-18 Combination therapy
PH12021550376A PH12021550376A1 (en) 2018-08-31 2021-02-23 Combination therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1814207.5A GB201814207D0 (en) 2018-08-31 2018-08-31 Combination Therapy

Publications (1)

Publication Number Publication Date
GB201814207D0 true GB201814207D0 (en) 2018-10-17

Family

ID=63920742

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1814207.5A Ceased GB201814207D0 (en) 2018-08-31 2018-08-31 Combination Therapy

Country Status (1)

Country Link
GB (1) GB201814207D0 (en)

Similar Documents

Publication Publication Date Title
IL277336A (en) Combination therapy
GB201804255D0 (en) Macrophage-based therapy
GB201819853D0 (en) Therapy
IL280968A (en) Combination therapy
IL279908A (en) Combination therapy
IL288237A (en) Combination therapy
IL280729A (en) Combination therapy
GB201906864D0 (en) Combination therapy
GB201817385D0 (en) Therapy
GB201818579D0 (en) New therapy
GB201814036D0 (en) New therapy
GB201815579D0 (en) Combination therapy
GB201814207D0 (en) Combination Therapy
ZA202200731B (en) Combination therapy
GB201820895D0 (en) Therapy
GB201805660D0 (en) Combination Therapy
GB201805189D0 (en) Combination therapy
GB201802947D0 (en) Combination therapy
GB201814038D0 (en) Ilven therapy
GB201919301D0 (en) Combination therapy
GB201917254D0 (en) Combination therapy
GB201914006D0 (en) Combination Therapy
GB201910473D0 (en) Combination therapy
GB201908227D0 (en) Combination therapy
GB201908231D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)